Scripps MD Anderson Cancer Center

https://www.Scripps.org/HemOncCME

 

Diagnosis and Management of Melanoma
18:34

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Melanoma Art and Science, Yesterday and Today: Early History & Factors Influencing the Development of Melanoma

FEATURING James Patterson
  • 15 views
  • March 5, 2020
12:30

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Melanoma Art and Science, Yesterday and Today: Overview of the Advances in the Pathology of Melanoma

FEATURING James Patterson
  • 13 views
  • March 5, 2020
16:10

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Melanoma Art and Science, Yesterday and Today: Overview of the More Recent Diagnostic Advances

FEATURING James Patterson
  • 11 views
  • March 5, 2020
21:50

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Pathology of Melanoma: Overview of Morphologic Subtypes, Staging & Reporting, and Prognostic Indicators

FEATURING Cora S. Humberson
  • 417 views
  • March 5, 2020
  • 3
30:18

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Overview of Dermoscopy and New Diagnostic Techniques in Melanoma

FEATURING Travis W. Blalock
  • 44 views
  • March 6, 2020
  • 1
20:17

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

The Evidence for a Large Role of UV Exposure in the Development of Cutaneous Melanoma Continues To Build

FEATURING Ashley Wysong
  • 8 views
  • March 6, 2020
16:08

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Dysplastic Nevi: Why Are They Important, Clinical & Histologic Criteria, and Historical Overview

FEATURING Benjamin Kelley
  • 11 views
  • March 6, 2020
06:45

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Management of Dysplastic Nevi: What Is the Best Way to Biopsy? Should They Be Re-excised?

FEATURING Benjamin Kelley
  • 7 views
  • March 6, 2020
22:07

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

2020 Update on Sentinel Node Biopsy: Does Early Treatment of Lymph Node Primary Melanoma Improve Outcomes?

FEATURING Merrick Ross
  • 48 views
  • March 6, 2020
16:03

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Is Completion Node Dissection for Positive Sentinel Nodes Necessary?

FEATURING Merrick Ross
  • 81 views
  • March 6, 2020
09:26

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

SNL & the Impact on Adjuvant Therapy Decision Making: Early Initiation of Systemic Therapy May Be Important

FEATURING Merrick Ross
  • 356 views
  • March 6, 2020
22:33

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

H&N Surgeon’s Perspective on Melanoma Management: Close Surveillance or CLND Are Equivalent for +SLND Biopsy Pts

FEATURING Christopher Bergeron
  • 6 views
  • March 6, 2020
21:02

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Neoadjuvant IO and Targeted Therapy for Advanced Resectable Melanoma: The Ability to Achieve pCR Correlates With Improved RFS

FEATURING Merrick Ross
  • 271 views
  • March 9, 2020
08:42

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Neoadjuvant Therapy for Advanced Resectable Melanoma: T-VEC OPTIM Trial Results + Future Neoadjuvant Strategies

FEATURING Merrick Ross
  • 20 views
  • March 9, 2020
18:02

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

In the Era of Immunotherapy, Is There a Role for Radiation Therapy in Melanoma?

FEATURING Prabhakar Tripuraneni
  • 44 views
  • March 9, 2020
20:10

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Evaluation of Melanonychia: Complete Surgical Removal of Atypical Lesions Is Recommended Because of the Risk of Progression to Melanoma

FEATURING Frederick S. Fish
  • 29 views
  • March 9, 2020
29:33

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Initial Biopsy Determines the Diagnosis/Staging, Work-up, Treatment, and Prognosis of Melanoma - Optimal Technique Is Essential

FEATURING Ashley Wysong
  • 9 views
  • March 9, 2020
29:15

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Practice Changing Data on Adjuvant Therapy in Advanced Stage Melanoma: Is There Any Role for Hi-dose IFN? / Is CLND Necessary Prior to Adjuvant Therapy?

FEATURING Kathryn Bollin
  • 50 views
  • March 9, 2020
18:43

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

New Tools for Melanoma Diagnosis: Gene Expression Profiling, Chromosome Copy Number Alterations (FISH, NGS, SNP Array)

FEATURING Kathleen M. Murphy
  • 80 views
  • March 9, 2020
08:58

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

New Tools for Melanoma Prognosis: Gene Expression Profiling & Identification of Somatic Mutations

FEATURING Kathleen M. Murphy
  • 36 views
  • March 9, 2020
17:09

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Oncolytic IO Intralesional Monotherapy in Melanoma: Greatest Response in Stage IIIB/C/D and IV With Systemic Effects Observed

FEATURING Merrick Ross
  • 50 views
  • March 9, 2020
12:28

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Oncolytic IO Intralesional Combination Therapy for Treatment Naive Patients With Unresectable Stage IIIB/C Melanoma

FEATURING Merrick Ross
  • 61 views
  • March 9, 2020
21:49

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Overview of Metastatic Evaluation of the Melanoma Patient: Sentinel Lymph Node Biopsy, Ultrasound, X-Ray, CT, MRI & Surveillance

FEATURING Douglas Winstanley
  • 28 views
  • March 9, 2020
12:20

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Update on Systemic Therapy for Advanced Melanoma: Long-Term Outcomes of CPIs and Targeted Therapy - Results of CM-067, and COMBI-D/V Trials

FEATURING Kathryn Bollin
  • 91 views
  • March 9, 2020
14:32

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Systemic Therapy for Advanced Melanoma: Long-Term Outcomes of IO in Brain Metastasis - Results of CheckMate 204-A Trial

FEATURING Kathryn Bollin
  • 117 views
  • March 9, 2020
17:57

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Cutaneous Adverse Events to CPI Therapy in Melanoma Treatment + Cutaneous Adverse Events of Activated BRAF MAPK Pathway

FEATURING Aleksandr Itkin
  • 6 views
  • March 9, 2020
20:12

Melanoma 2020: 30th Annual Cutaneous Malignancy Update

Evaluation of the Melanoma Patient for Other Primary Melanoma Lesions: Risk Factors in Multiple Melanoma + Survival Data on SPM & MPM Pts

FEATURING Frederick S. Fish
  • 5 views
  • March 9, 2020